Shareholders that lost money on Intellia Therapeutics, Inc.(NTLA) should contact Levi & Korsinsky about pending Class Action - NTLA
Portfolio Pulse from
Shareholders of Intellia Therapeutics, Inc. (NTLA) who incurred losses are encouraged to contact Levi & Korsinsky for information on a potential class action lawsuit for recovery under federal securities laws.
March 16, 2025 | 12:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Intellia Therapeutics is facing a potential class action lawsuit, and shareholders who suffered losses are advised to seek legal counsel for possible recovery.
The news of a potential class action lawsuit against Intellia Therapeutics is likely to negatively impact its stock price in the short term as it raises concerns about legal liabilities and investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100